Health Accounts for Chronic Condition Management

Individuals managing chronic conditions face predictable, recurring medical costs that can be strategically paired with tax-advantaged health accounts to reduce out-of-pocket burden. This page explains how Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs) function in the context of ongoing treatment, prescription regimens, and specialist care. Understanding which account types align with specific conditions and coverage structures determines how much tax savings a household can realistically capture. For broader orientation on how these accounts fit the regulatory landscape, the home resource index provides a structured starting point.

Definition and scope

Health accounts for chronic condition management refers to the deliberate use of IRS-authorized tax-advantaged accounts to fund the predictable and recurring expenses associated with long-term medical conditions — including diabetes, hypertension, asthma, autoimmune disorders, and musculoskeletal diseases.

The Internal Revenue Service defines qualified medical expenses under Internal Revenue Code §213(d), which governs what costs HSAs, FSAs, and HRAs may reimburse on a pre-tax basis. Expenses must be primarily for the diagnosis, cure, mitigation, treatment, or prevention of disease. This definition encompasses a wide range of chronic-condition costs:

Prescription medications (including insulin, which was explicitly clarified as an HSA-eligible expense under the CARES Act of 2020)
Durable medical equipment (glucose monitors, CPAP machines, nebulizers)
Specialist office visits and laboratory tests
Physical therapy and medically necessary occupational therapy
Mental health treatment related to a diagnosed condition

The scope of chronic condition management within health accounts is national in reach: the Centers for Disease Control and Prevention reports that 6 in 10 adults in the United States have at least one chronic disease, making this the dominant use case for tax-advantaged health spending rather than an edge scenario.

How it works

The mechanics differ by account type, but all three function by sheltering dollars from income taxation before or at the point of medical spending.

Health Savings Account (HSA)

An HSA is available only to individuals enrolled in a High-Deductible Health Plan (HDHP). For 2024, the IRS set the minimum HDHP deductible at $1,600 for self-only coverage and $3,200 for family coverage (IRS Revenue Procedure 2023-23). Contributions are deductible or pre-tax, growth is tax-free, and withdrawals for qualified expenses are tax-free — the "triple tax advantage" described by the IRS in Publication 969.

For chronic condition management, HSAs offer a structurally important feature: unused balances roll over indefinitely and can be invested. A person with a long-term condition can accumulate HSA assets during lower-expense periods and draw on them during high-cost treatment phases without forfeiture.

For 2024, the HSA contribution limit is $4,150 for self-only coverage and $8,300 for family coverage, with a $1,000 catch-up contribution permitted for individuals aged 55 and older (IRS Rev. Proc. 2023-23).

Flexible Spending Account (FSA)

FSAs do not require HDHP enrollment, making them accessible to individuals on lower-deductible plans who may prefer richer coverage for frequent specialist visits. The 2024 FSA contribution limit is $3,200 per employee (IRS Rev. Proc. 2023-34). The critical limitation for chronic condition management is the use-it-or-lose-it rule: funds not spent by the plan year deadline (or a grace period of up to 2.5 months, or a carryover of up to $640 in 2024) are forfeited.

For individuals with highly predictable annual costs — a fixed prescription regimen, scheduled infusion treatments — FSA contributions can be calibrated accurately enough to minimize forfeiture risk.

Health Reimbursement Arrangement (HRA)

HRAs are employer-funded and do not involve employee contributions. An Individual Coverage HRA (ICHRA) or a Qualified Small Employer HRA (QSEHRA) can reimburse premiums and qualified expenses, making them relevant for individuals managing chronic conditions who are covered through an employer plan with HRA support. The IRS finalizing rules for ICHRAs in 2019 established that employees can use ICHRA funds to pay for individual market premiums and out-of-pocket costs, giving employers flexibility to support high-cost-condition employees without structuring a traditional group plan.

Common scenarios

The following structured breakdown illustrates how account selection plays out across four representative chronic condition profiles:

Type 2 Diabetes (insulin-dependent): Insulin, glucose test strips, continuous glucose monitors, and diabetic footwear are all §213(d)-qualified expenses. An HSA paired with an HDHP is optimal when the individual is otherwise healthy enough to tolerate higher deductibles; the investment growth potential offsets short-term out-of-pocket exposure.
Asthma with regular inhaler and pulmonology visits: Predictable annual costs suit FSA planning. If total annual inhaler, copay, and spirometry costs consistently total approximately $2,400, FSA contributions can be set at that amount with minimal forfeiture risk.
Rheumatoid Arthritis requiring biologic infusion therapy: Biologic medications frequently carry annual costs exceeding $20,000 at list price. HSA funds can cover deductibles and cost-sharing, while coordination with manufacturer patient assistance programs may reduce the net spend that must be covered by account dollars. The regulatory context for health savings explains how IRS rules interact with third-party payment programs.
Hypertension with multiple medications and cardiac monitoring: A stable prescription regimen and annual cardiology panels make FSA funding straightforward. Individuals on employer plans without HDHP access rely on FSAs or employer HRA contributions for pre-tax coverage.

Decision boundaries

Selecting the right account type for a chronic condition requires weighing four distinct variables:

Account compatibility with plan type

HSA eligibility is blocked by enrollment in a non-qualifying HDHP, Medicare, or a spouse's FSA (unless structured as a Limited-Purpose FSA). The IRS eligibility rules under IRC §223 are the binding standard. Individuals who have already enrolled in Medicare Part A or B cannot contribute to an HSA, even if they remain employed — a common boundary issue for older adults still managing active treatment.

Predictability of annual spending

Chronic conditions with stable, predictable costs favor FSAs: contributions can match expected spending closely. Conditions with variable cost trajectories — episodic flares, potential surgery, changing medication regimens — favor HSAs, where unused balances accumulate rather than expire.

Employer plan design

If an employer offers only a traditional low-deductible PPO, HSA access is unavailable. Employees in that position are limited to FSAs or employer-funded HRAs. The presence of a QSEHRA or ICHRA at a small employer may be the only available tax-advantaged vehicle.

Coordination across accounts

HSAs and general-purpose FSAs cannot be held simultaneously under IRS rules. However, a Limited-Purpose FSA (restricted to dental and vision) can coexist with an HSA. Individuals managing chronic conditions who want both HSA investment growth and FSA accessibility for dental costs can use this combination structure — detailed further in the site's coverage of coordinating multiple health accounts.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)